Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial
Methylsulfonylmethane (MSM) is a food ingredient present in small amounts in many foods, and its anti-inflammatory effects have been reported. We conducted a randomized, double-blind, placebo-controlled trial of oral consumption of MSM on mild pain of the knee joint in healthy Japanese participants....
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/13/2995 |
_version_ | 1797591083320868864 |
---|---|
author | Akifumi Toguchi Naoto Noguchi Toshihiro Kanno Akira Yamada |
author_facet | Akifumi Toguchi Naoto Noguchi Toshihiro Kanno Akira Yamada |
author_sort | Akifumi Toguchi |
collection | DOAJ |
description | Methylsulfonylmethane (MSM) is a food ingredient present in small amounts in many foods, and its anti-inflammatory effects have been reported. We conducted a randomized, double-blind, placebo-controlled trial of oral consumption of MSM on mild pain of the knee joint in healthy Japanese participants. A total of 88 participants were enrolled in this study and randomly assigned to MSM consumption (<i>n</i> = 44) and placebo control (<i>n</i> = 44) groups. Both groups of participants took 10 tablets, each containing 200 mg MSM or lactose, per day for 12 weeks. The primary outcome of this study was measured values of the total score of the Japanese Knee Osteoarthritis Measure (JKOM) at 12 weeks after the test sample consumption. Safety evaluation was performed through physical examination, urine analysis, peripheral blood test, and medical interview. The total scores at 12 weeks in the MSM and placebo groups as the primary outcome were significantly different (<i>p</i> = 0.046). The health condition of JKOM also improved after MSM consumption (<i>p</i> = 0.032). The questionnaire results also suggested improvement in the knee and systemic health. This study indicated that MSM oral consumption improved both knee and systemic health conditions in healthy participants who experienced mild pain in the knee joint. |
first_indexed | 2024-03-11T01:32:30Z |
format | Article |
id | doaj.art-a33a5e59036a4c87b9b73ef0cf1190d7 |
institution | Directory Open Access Journal |
issn | 2072-6643 |
language | English |
last_indexed | 2024-03-11T01:32:30Z |
publishDate | 2023-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Nutrients |
spelling | doaj.art-a33a5e59036a4c87b9b73ef0cf1190d72023-11-18T17:15:33ZengMDPI AGNutrients2072-66432023-06-011513299510.3390/nu15132995Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled TrialAkifumi Toguchi0Naoto Noguchi1Toshihiro Kanno2Akira Yamada3Department of Research and Development, Chlorella Industry Co., Ltd., Hisatomi 1343, Chikugo 833-0056, Fukuoka, JapanDepartment of Research and Development, Chlorella Industry Co., Ltd., Hisatomi 1343, Chikugo 833-0056, Fukuoka, JapanDepartment of Research and Development, Chlorella Industry Co., Ltd., Hisatomi 1343, Chikugo 833-0056, Fukuoka, JapanResearch Center for Innovative Cancer Therapy, Kurume University, Kurume 830-0011, Fukuoka, JapanMethylsulfonylmethane (MSM) is a food ingredient present in small amounts in many foods, and its anti-inflammatory effects have been reported. We conducted a randomized, double-blind, placebo-controlled trial of oral consumption of MSM on mild pain of the knee joint in healthy Japanese participants. A total of 88 participants were enrolled in this study and randomly assigned to MSM consumption (<i>n</i> = 44) and placebo control (<i>n</i> = 44) groups. Both groups of participants took 10 tablets, each containing 200 mg MSM or lactose, per day for 12 weeks. The primary outcome of this study was measured values of the total score of the Japanese Knee Osteoarthritis Measure (JKOM) at 12 weeks after the test sample consumption. Safety evaluation was performed through physical examination, urine analysis, peripheral blood test, and medical interview. The total scores at 12 weeks in the MSM and placebo groups as the primary outcome were significantly different (<i>p</i> = 0.046). The health condition of JKOM also improved after MSM consumption (<i>p</i> = 0.032). The questionnaire results also suggested improvement in the knee and systemic health. This study indicated that MSM oral consumption improved both knee and systemic health conditions in healthy participants who experienced mild pain in the knee joint.https://www.mdpi.com/2072-6643/15/13/2995methylsulfonylmethaneknee painJKOM |
spellingShingle | Akifumi Toguchi Naoto Noguchi Toshihiro Kanno Akira Yamada Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial Nutrients methylsulfonylmethane knee pain JKOM |
title | Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_full | Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_fullStr | Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_full_unstemmed | Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_short | Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial |
title_sort | methylsulfonylmethane improves knee quality of life in participants with mild knee pain a randomized double blind placebo controlled trial |
topic | methylsulfonylmethane knee pain JKOM |
url | https://www.mdpi.com/2072-6643/15/13/2995 |
work_keys_str_mv | AT akifumitoguchi methylsulfonylmethaneimproveskneequalityoflifeinparticipantswithmildkneepainarandomizeddoubleblindplacebocontrolledtrial AT naotonoguchi methylsulfonylmethaneimproveskneequalityoflifeinparticipantswithmildkneepainarandomizeddoubleblindplacebocontrolledtrial AT toshihirokanno methylsulfonylmethaneimproveskneequalityoflifeinparticipantswithmildkneepainarandomizeddoubleblindplacebocontrolledtrial AT akirayamada methylsulfonylmethaneimproveskneequalityoflifeinparticipantswithmildkneepainarandomizeddoubleblindplacebocontrolledtrial |